Clinical Trials Directory

Trials / Completed

CompletedNCT02074358

A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Bristol-Myers Squibb · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the effect of two 4-Factor PCC formulations on Apixaban pharmacodynamics in healthy adult subjects.

Conditions

Interventions

TypeNameDescription
DRUGApixaban
DRUGCofact (4-Factor PCC)
DRUGBeriplex P/N (4-Factor PCC)
DRUGPlacebo (Saline solution)

Timeline

Start date
2014-02-01
Primary completion
2014-04-01
Completion
2014-04-01
First posted
2014-02-28
Last updated
2015-08-13
Results posted
2015-08-13

Source: ClinicalTrials.gov record NCT02074358. Inclusion in this directory is not an endorsement.

A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult (NCT02074358) · Clinical Trials Directory